Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button

Home > Press > New Research Demonstrates Potential of T2 Biosystemís Novel Portable, Rapid Nanoscale MR-based Diagnostic Technology

Abstract:
Findings Published in Nature Medicine

New Research Demonstrates Potential of T2 Biosystemís Novel Portable, Rapid Nanoscale MR-based Diagnostic Technology

Cambridge, MA | Posted on July 15th, 2008

T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced significant research findings that demonstrate the superior efficacy of the Company's nanoparticle-based, magnetic resonance diagnostic technology in a new miniaturized prototype. The findings appear in Nature Medicine in an article entitled "Chip-NMR biosensor for detection and molecular analysis of cells."

The findings published in Nature Medicine show the clinical potential and exquisite sensitivity of T2's technology as a robust and portable diagnostic device for multiplexed, quantitative and rapid analysis within a miniaturized prototype. In the study, a prototype device developed by the investigators at the Massachusetts General Hospital and Harvard University performed measurements on biological samples, accurately detecting bacteria with high sensitivity, identifying small numbers of cells and analyzing them on a molecular level in real time, while measuring a series of protein biomarkers in parallel. The results showed the prototype distinguished between simulated blood samples representing healthy individuals, those with cancer, and those with diabetes, by looking for eight different biomarker molecules and also demonstrated it is sensitive enough to detect just 10 bacteria in a given sample.

This new research demonstrates the clinical potential of T2's technology, through new methods of advancing and developing magnetic resonance-based diagnostics, which will ultimately offer improved speed, accuracy and efficiency as well as portability to a broader range of settings including doctor's offices, homes and hospitals.

"This exciting data shows that this T2 technology-based prototype is currently two to three orders of magnitude more sensitive than the standard NMR scanners used in many laboratories today, and the revolutionary potential this technology can bring to bear on the field of clinical diagnostics," said Ralph Weissleder, Ph.D., author of the paper, co-founder of T2 Biosystems and Professor, Harvard Medical School. "This novel technology will ultimately enable immediate, accurate diagnostic testing for nearly any health condition, in nearly any setting."

"This exciting data is a continued validation of the breakthrough potential of T2's novel technology," said John McDonough, CEO of T2 Biosystems. "This data further demonstrates the robust capabilities of our portable diagnostics platform and the potential to improve health care by providing accurate and rapid diagnostic results in virtually any healthcare setting."

T2 Biosystems is developing the next generation of medical diagnostic products through its proprietary technology, which combines nanotechnology and the miniaturization of proven MR technology to develop rapid, accurate and portable diagnostics. T2 Biosystems' technology has been validated in multiple published journal articles and has shown to accurately analyze viruses, bacteria, proteins, hormones, DNA, small molecules and other diagnostic targets. The Company is developing a pipeline of diagnostic products based on its technology, including devices for hospitals, diagnostic laboratories and medical offices, as well as individual patients.

####

About T2 Biosystems, Inc.
T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology, combining nanotechnology and miniaturized magnetic resonance (MR) technology to provide rapid, accurate and portable diagnostics. T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute of Technology, Harvard University, Harvard Medical School and Massachusetts General Hospital, and has assembled a world-class team, board of directors and scientific advisory board that collectively have a proven track record of translating technologic innovations into breakthrough products, building significant corporate value. T2 Biosystems is located in Cambridge, Massachusetts.

For more information, please click here

Contacts:
Yates Public Relations
Kathryn Morris
845-635-9828

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists change properties of zeolites to improve hemodialysis July 29th, 2016

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

Beating the heat a challenge at the nanoscale: Rice University scientists detect thermal boundary that hinders ultracold experiments July 28th, 2016

Imaging

Lonely atoms, happily reunited July 29th, 2016

Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016

Nanomedicine

Scientists change properties of zeolites to improve hemodialysis July 29th, 2016

Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016

Starpharma initiates new DEPô drug delivery program with AstraZeneca July 27th, 2016

Scientists test nanoparticle drug delivery in dogs with osteosarcoma July 26th, 2016

Announcements

Scientists change properties of zeolites to improve hemodialysis July 29th, 2016

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

Tools

Lonely atoms, happily reunited July 29th, 2016

Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016

WSU researchers 'watch' crystal structure change in real time: Breakthrough made possible by new Argonne facility July 27th, 2016

Enhancing molecular imaging with light: New technology platform increases spectroscopic resolution by 4 fold July 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic